ABO ppt
-
Upload
patricia-denise-orquia -
Category
Documents
-
view
213 -
download
0
Transcript of ABO ppt
8/20/2019 ABO ppt
http://slidepdf.com/reader/full/abo-ppt 1/21
U N I T VI
Textbook of Medical Physiology, 11th Edition
GUYTON & HALL
Copyright © 2006 by Elsevier, Inc.
Chapter 35:Blood Types; Transfusion;
Tissue and Organ Transplantation
Slides by Robert L. Hester, Ph.D.
8/20/2019 ABO ppt
http://slidepdf.com/reader/full/abo-ppt 2/21
Copyright © 2006 by Elsevier, Inc.
Overview of Blood Types
• Blood Video\What are Blood Types-.mp4
8/20/2019 ABO ppt
http://slidepdf.com/reader/full/abo-ppt 3/21
Copyright © 2006 by Elsevier, Inc.
Blood Groups
Red blood cell surface antigens: glycolipids or glycoproteins
A-B-O Systemagglutinogens: surface antigens (A,B)
genes (A, B, O)
inherited (two surface chromosomes)
OO OA OB AA BB AB
also present on all cells in the body
agglutinins: gamma globulins, anti-A, anti-B, IgM, IgG
8/20/2019 ABO ppt
http://slidepdf.com/reader/full/abo-ppt 4/21
Copyright © 2006 by Elsevier, Inc.
Blood Groups
GENOTYPE BLOOD TYPE AGGLUTINOGENS AGGLUTININS
OO
OA or AA
OB or BB
AB
O
A
B
AB
------
A
B
AB
ANTI-A
ANTI-B
ANTI-A and
ANTI-B
------
8/20/2019 ABO ppt
http://slidepdf.com/reader/full/abo-ppt 5/21
Copyright © 2006 by Elsevier, Inc.
Titer of Agglutinins
• After birth – almostzero
• 2-8 months after birth – begin production
• 8-10 years old – maximum titer
• Gradually declinesremaining years of life
8/20/2019 ABO ppt
http://slidepdf.com/reader/full/abo-ppt 6/21
Copyright © 2006 by Elsevier, Inc.
Blood Typing
BLOOD TYPE ANTI-A ANTI-B
O
A
B
AB
------
++
------
------
+
+
------
8/20/2019 ABO ppt
http://slidepdf.com/reader/full/abo-ppt 7/21Copyright © 2006 by Elsevier, Inc.
Blood Groups
Rhesus System
agglutinogens: 6 rhesus factors (C, D, E, c, d, e)
inherited as triplets
CDE, CDe, Cde, CdE, cDE, cDe, cde
antigen D =Rhesus positive (widely
prevalent & more antigenic)
agglutinins: do not occur spontaneously, only after
exposure to Rh antigens
Rh+ blood into Rh negative person:
sensitization to further Rh+ transfusion
8/20/2019 ABO ppt
http://slidepdf.com/reader/full/abo-ppt 8/21Copyright © 2006 by Elsevier, Inc.
•Disease of the fetus and newborn child
•Fetal blood enters maternal circulation
•Agglutination & phagocytosis of fetus’ RBCs
• ABO incompatibility
•O mother and A or B fetus
•IgG anti-A and anti-B cross placenta
•very mild effects
Hemolytic Disease of the Newborn or
Erythroblastosis fetalis
8/20/2019 ABO ppt
http://slidepdf.com/reader/full/abo-ppt 9/21Copyright © 2006 by Elsevier, Inc.
•Rh incompatibility
•Rh positive fetus and a Rh negative mother
•Anti-D agglutinins form in mother from exposure to
fetus’ Rh Ag
diffusion thru the placenta into the fetusand cause agglutination
•Maternal blood with anti-D usually circulate in infant’s
blood for another 1-2 months after birth destroys more
RBC
•More critical with 2nd and succeeding Rh positive child
Hemolytic Disease of the Newborn or
Erythroblastosis fetalis
8/20/2019 ABO ppt
http://slidepdf.com/reader/full/abo-ppt 10/21Copyright © 2006 by Elsevier, Inc.
Hemolytic Disease of the Newborn or
Erythroblastosis fetalis
• Signs and Symptoms
1. Jaundice
2. Pallor or anemia at birth3. Hepatosplenomegaly – forming nucleated blastic
RBCs
4. kernicterus
8/20/2019 ABO ppt
http://slidepdf.com/reader/full/abo-ppt 11/21Copyright © 2006 by Elsevier, Inc.
• Treatment
1. Exchange Transfusion
• Replace neonate’s blood with Rh (-) blood
• > 6 weeks - transfused Rh (-) blood is replaced byinfant’s own Rh (+) blood and mother’s anti-D is
destroyed
2. Injection of IgG anti-D or Rh Ig or Rhogam
• to expectant mother starting at 28-30 weeks AOG
Hemolytic Disease of the Newborn or
Erythroblastosis fetalis
8/20/2019 ABO ppt
http://slidepdf.com/reader/full/abo-ppt 12/21Copyright © 2006 by Elsevier, Inc.
• Prevention
• Administer Rhogam to Rh (-) mother who delivered
Rh (+) babies to prevent sensitization of mother to
the D Ag, thus, reducing the risk of developing largeamounts of anti-D during 2nd pregnancy
Mechanism of Rhogam
• inhibits Ag-induced B lymphocytic Ab production in
expectant mothers• Attaches to D-Ag sites on Rh (+) fetal RBC that
may cross the placenta
Hemolytic Disease of the Newborn or
Erythroblastosis fetalis
8/20/2019 ABO ppt
http://slidepdf.com/reader/full/abo-ppt 13/21Copyright © 2006 by Elsevier, Inc.
Transfusion Reaction
Hemolysins – IgG agglutinins contain 2 binding sites
– IgM agglutinins contain 10 binding sites
Agglutination = “clumping” of cells by activation ofcomplement system (Ag-Ab reaction) release
proteolytic enzymes destroys membrane of
agglutinated cells (either by physical distortion ofcells or phagocytosis by WBC) release of Hb hemolysis
8/20/2019 ABO ppt
http://slidepdf.com/reader/full/abo-ppt 14/21Copyright © 2006 by Elsevier, Inc.
Transfusion Reaction
• Transfusion reaction due to agglutination of
donor blood and rarely recipient’s blooddue to – plasma portion of donor blood
immediately becomes diluted by plasma of
recipient decreasing titer of transfused
agglutinins
• DONOR’S BLOOD undergoes hemolysis
8/20/2019 ABO ppt
http://slidepdf.com/reader/full/abo-ppt 15/21Copyright © 2006 by Elsevier, Inc.
Transfusion Reaction
• Signs and Symptoms
1. Fever and chills2. Shortness of breath
3. Jaundice
4. Shock
5. Renal shutdown
8/20/2019 ABO ppt
http://slidepdf.com/reader/full/abo-ppt 16/21Copyright © 2006 by Elsevier, Inc.
Transfusion Reaction
• Renal Shotdown or Renal Failure1. Renal Vasoconstrictor – toxic substance
released by hemolyzed blood
2. Circulatory Shock –
due to loss of circulatingRBC, the produced toxic substances and fromimmune reaction (Ag-Ab reaction) – hypotension,decrease renal blood flow, decrease urine output
3. Renal Tubular Blockage – total amount of free
Hb released into the circulating blood > Hbbound to haptoglobin excess leaks thru theglomerular membrane into kidney tubules, whichprecipitates and blocks renal tubules
8/20/2019 ABO ppt
http://slidepdf.com/reader/full/abo-ppt 17/21Copyright © 2006 by Elsevier, Inc.
Transplantation
• Autograft – same animal
• Isograft – identical twin• Allograft – same species
• Xenograft – different species
8/20/2019 ABO ppt
http://slidepdf.com/reader/full/abo-ppt 18/21Copyright © 2006 by Elsevier, Inc.
Transplantation
• HLA Ab
– Most important Ab causing graft rejection
–150 Ab 6 on tissue cell membrane (WBC andtissue cells)
• HLA Typing – test for rate of trans-
membrane uptake by WBC of a special dye
• OBTAIN THE BEST POSSIBLE MATCH
8/20/2019 ABO ppt
http://slidepdf.com/reader/full/abo-ppt 19/21Copyright © 2006 by Elsevier, Inc.
Transplantation
• Rejection ---- mainly due to activation ofT-cells
• Suppressive therapy---- inhibit immune
response not protected from infectiousdiseases and sometimes even cancer
1. glucocorticoids – limits growth of all lymphoidtissuesdecrease formation of Ab and T cells
2. azathioprine - inhibits formation of Ab and T cells3. cyclosporine --- specific inhibitor of helper T-cell
formation; most valuable because it does notsuppress other portions of the immune system
8/20/2019 ABO ppt
http://slidepdf.com/reader/full/abo-ppt 20/21Copyright © 2006 by Elsevier, Inc.
RECAP
• Blood Video\Blood Types.mp4